These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16076274)

  • 21. Treatment of unprotected left main coronary artery stenosis in the drug-eluting stent era.
    Tanigawa J; Sutaria N; Goktekin O; Di Mario C
    J Interv Cardiol; 2005 Dec; 18(6):455-65. PubMed ID: 16336426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
    Moussa I; Costa RA; Leon MB; Lansky AJ; Lasic Z; Cristea E; Trubelja N; Carlier SG; Mehran R; Dangas GD; Weisz G; Kreps EM; Collins M; Stone GW; Moses JW
    Am J Cardiol; 2006 May; 97(9):1317-21. PubMed ID: 16635603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-coated stents boost benefits of angioplasty. These tiny devices keep unclogged arteries open but don't prevent blockages from arising in other heart arteries.
    Harv Heart Lett; 2004 Jan; 14(5):4. PubMed ID: 14734293
    [No Abstract]   [Full Text] [Related]  

  • 25. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
    Huang HW; Brent BN; Shaw RE
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Still a future for the bare metal stent?
    Barlis P; Di Mario C
    Int J Cardiol; 2007 Sep; 121(1):1-3. PubMed ID: 17360051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of drug-eluting stents: current best available evidence.
    Raja SG; Dreyfus GD
    J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease.
    Sanmartín M; Baz JA; Claro R; Asorey V; Durán D; Pradas G; Iñiguez A
    Am J Cardiol; 2007 Sep; 100(6):970-3. PubMed ID: 17826380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left main drug-eluting stents: natural progression or a bridge too far?
    Stone GW; Moses JW; Leon MB
    J Am Coll Cardiol; 2007 Aug; 50(6):498-500. PubMed ID: 17678731
    [No Abstract]   [Full Text] [Related]  

  • 31. Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention.
    Noordeloos AM; Soullié T; Duckers HJ; Serruys PW
    Endothelium; 2006; 13(6):431-9. PubMed ID: 17169775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on drug-eluting coronary stents.
    Kipshidze NN; Tsapenko MV; Leon MB; Stone GW; Moses JW
    Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):953-68. PubMed ID: 16181039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The left main facts: faced, spun, but alas too few.
    Brinker J
    J Am Coll Cardiol; 2008 Mar; 51(9):893-8. PubMed ID: 18308156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short and long-term outcomes of two drug eluting stents in bifurcation lesions.
    Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; Wu Y; Dai J
    Chin Med J (Engl); 2007 Feb; 120(3):183-6. PubMed ID: 17355818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A dilemma choosing revascularization method in coronary disease. Drug-eluting stents not a given choice].
    Grip L
    Lakartidningen; 2007 Jun 4-11; 104(23):1774-5. PubMed ID: 17655020
    [No Abstract]   [Full Text] [Related]  

  • 38. Economic evaluation of drug-eluting stents in coronary angioplasty.
    Santos R; Pereira H
    Rev Port Cardiol; 2005 Nov; 24(11):1409-18. PubMed ID: 16463989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bifurcation stenting with drug eluting stents: illustration of the crush technique.
    Sianos G; Vaina S; Hoye A; Serruys PW
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):839-45. PubMed ID: 16649229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.